BioHeartland Launches as the New Identity for Indiana’s Bioscience Ecosystem

2026-05-19T10:30:26-04:00May 19, 2026|

New regional identity showcases the state’s ability to invent, make and move breakthroughs across human health, animal health and plant science, positioning Indiana to compete globally for bioscience investment, innovation and talent. INDIANAPOLIS (May 19, 2026) — Today, regional leaders introduced BioHeartland, a new shared identity designed to unify and elevate Indiana’s bioscience ecosystem across human health, animal health and plant science. Developed through a collaborative effort led by the CEOs of Indiana Corporate Partnership (CICP) and its branded initiatives, BioCrossroads and AgriNovus Indiana, in partnership with the Central Indiana Regional Development Authority, BioHeartland was created to give Indiana a more cohesive and unified way to share the state’s story with investors, companies, researchers and talent around the world. For more than a century, Indiana has steadily helped shape global health through leadership in research, development, manufacturing and logistics [...]

Lilly Endowment and CICP announce the launch of a new annual endowed life sciences speaker series in recognition of the 150th anniversary of Eli Lilly and Company

2026-05-12T13:04:14-04:00May 12, 2026|

INDIANAPOLIS – Lilly Endowment Inc. and the CEOs of Indiana Corporate Partnership (CICP) today unveiled during the “150 Years of Medicine” celebration at the recently completed Lilly Event Center a new annual speaker series that will bring to Indiana world-renowned experts in important and timely topics regarding life sciences. “The annual series is endowed through a $10 million grant from Lilly Endowment to the CICP Foundation in tribute to the role the Endowment’s founders played in developing and leading Eli Lilly and Company during its first century and in recognition of the company’s 150th anniversary. The speaker series will help raise the profile and build on the state’s national leadership in the life sciences,” said N. Clay Robbins, Lilly Endowment’s Chairman and CEO. “Indiana is home to some of the world’s most innovative life sciences companies and research institutions, [...]

Central Indiana excelling in life sciences, but it needs a brand, speakers say

2026-04-28T15:19:54-04:00April 28, 2026|

This post was originally published by Indianapolis Business Journal. Click here to read the original article. Central Indiana is a world leader in life sciences innovation, but the region needs to develop a distinct brand and message to continue its momentum, speakers said Thursday at IBJ’s Life Sciences Power Breakfast. Keynote speaker Chad Shearer, director of research for New York-based The Global Institute on Innovation Districts, told an audience of about 350 attendees in the life sciences sector that central Indiana stands apart as a region in nearly every category of invention and innovation. The CEOs of Indiana Corporate Partnership hired The Global Institute on Innovation Districts to help it develop a unified brand and message around life sciences, identify the region, encourage investment, attract talent and set the region apart globally as a hub for research, development and [...]

David Rosenberg: Future of American biotech is being built in Indianapolis

2026-04-28T15:00:42-04:00April 28, 2026|

This post was originally published by Indianapolis Business Journal. Click here to read the original article. Last year, a small team of scientists in Indianapolis discovered a method for the early detection of pancreatic cancer, one of the deadliest cancers precisely because it’s so hard to catch in time. Despite what you might assume, these scientists weren’t working out of a gleaming coastal research campus or a well-capitalized Silicon Valley lab. They were members of a startup called Amplified Sciences, operating out of an accelerator in Indiana, surviving on non-dilutive federal funding while racing to close the gap between a promising discovery and a product that could reach patients. This discovery wasn’t a miracle. It was the result of an entire bioscience ecosystem strategically built here in central Indiana. Earlier this month, U.S. Sen. Todd Young held a field hearing in [...]

Braun: $1B state investment in Indiana’s life sciences expected to create 100K jobs

2026-03-17T14:22:45-04:00March 17, 2026|

This post was originally published by Indianapolis Business Journal. Click here to read the original article. Seeking to position Indiana as a global leader in agritechnology and life sciences, Gov. Mike Braun unveiled a lofty goal in a public announcement Tuesday morning. Speaking at a press conference with Secretary of Commerce David Adams, Braun said the state will invest $1 billion over 10 years to boost life sciences-related businesses, with the goal of creating 100,000 jobs in those sectors. Braun said the new investment into human therapeutics, animal health, agritech, biotechnology and environmental innovation are part of his goal to create regional economic development plans by region. He said the Central Indiana Regional Development Authority, or CIRDA, will serve as the first “regional steward” over the initiative. CIRDA, an economic development alliance, represents more than 30 cities, towns and [...]

AnalytiXIN creates new Indiana healthcare-based consortium to advance data-driven clinical research and improve health outcomes

2025-02-10T19:37:46-05:00January 21, 2025|

New shared platform will use consented health data to facilitate life sciences research, advance healthcare, and to engage patients via precision medicine INDIANAPOLIS – AnalytiXIN today announced the launch of a new consortium to help healthcare organizations across Indiana better identify and access comprehensive, consented clinical and genomic health data. It is a continued investment to improve patient outcomes and drive efficiencies to accelerate clinical research. Access to these diverse datasets will allow researchers to quickly develop and conduct more accurate and personalized studies, enabling more effective healthcare interventions, further establishing Indiana as a leader in health sciences data analytics. Several leading Indiana-based healthcare companies, including Eli Lilly and Company (“Lilly”), Indiana University (IU) Health, IU School of Medicine, and the Indiana Health Information Exchange (IHIE) have pledged unprecedented commitment to this collaboration. “We’re excited to work with our [...]

Central Indiana Corporate Partnership announces senior leadership appointments across BioCrossroads, Conexus Indiana and TechPoint

2024-12-19T00:27:36-05:00December 12, 2024|

INDIANAPOLIS – The Central Indiana Corporate Partnership (CICP), alongside its branded initiatives BioCrossroads, Conexus Indiana and TechPoint, today announces the appointment of three senior leaders who will play pivotal roles in shaping the future of Indiana’s life sciences, advanced manufacturing and logistics and technology sectors. Douglas Kiehl, Patrick “PJ” McGrew and Casey Osterkamp joined BioCrossroads, Conexus Indiana and TechPoint, respectively, in senior leadership roles on December 10. “As we ensure the strength of Indiana’s advanced industries, these strategic hires underscore our commitment to building a thriving, innovative economy,” said Melina Kennedy, CEO of the Central Indiana Corporate Partnership. “Doug, PJ and Casey each bring a depth of expertise that will help us tackle workforce challenges, advance technological adoption and foster cross-sector collaboration. Together, they will elevate our efforts to position Indiana as a global leader in innovation and talent [...]

WISH-TV: BioCrossroads is working to grow life sciences in Indiana

2024-04-15T12:05:47-04:00April 15, 2024|

BioCrossroads President and CEO Vince Wong was recently featured on WISH-TV's Business, Equity and Opportunities show with Scott Sander to talk about the growth of the life sciences in Indiana. Indiana is ranked first in the nation for pharmaceutical exports and second in the nation for life sciences exports. Indiana's life sciences sector: $95B annual economic contribution 67,000+ workers 3,000+ life sciences establishments $108,000+ average wage Wong talks about an area of growth for the sector including attracting companies that manufacture devices to treat and manage diseases. He also talks about the need to continue to attract talent into the growing sector. WATCH (Sources: WISH-TV and BioCrossroads)

Go to Top